Irish HSE rejects MS drug Fampridine again
Posted: Thu Oct 30, 2014 12:56 am
Irish health service executive rejects MS drug Fampridine again
Decision comes as a blow to patients who are paying up to €500 a month for Fampridine.
The Health Service Executive has rejected a second application from the makers of a drug that helps people with multiple sclerosis to walk to have it covered by State-funded drug schemes...... Read More - http://www.ms-uk.org/ampyra
Decision comes as a blow to patients who are paying up to €500 a month for Fampridine.
The Health Service Executive has rejected a second application from the makers of a drug that helps people with multiple sclerosis to walk to have it covered by State-funded drug schemes...... Read More - http://www.ms-uk.org/ampyra